Mouse Breeding and Procedure Core

$335,370P01FY2016HLNIH

New York University School Of Medicine, New York NY

Investigators

Linked publications & trials

Paper 31242034 Paper 31071002 Paper 30786741 Paper 30324836 Paper 29891593 Paper 29687324 Paper 29657854 Paper 29657853 Paper 29282247 Paper 29259621 Paper 28642238 Paper 28183700 Paper 27967251 Paper 27543804 Paper 27166197 Paper 27052179 Paper 26936329 Paper 26558318 Paper 26253613 Paper 26166707 Paper 26130225 Paper 25995044 Paper 25974754 Paper 25655894 Paper 25559887 Paper 24740187 Paper 24665121 Paper 24520121 Paper 24186862 Paper 24084731 Paper 24011512 Paper 23785412 Paper 23766264 Paper 23209312 Paper 23173756 Paper 22895668 Paper 22815341 Paper 22750165 Paper 22661511 Paper 22632267 Paper 22511750 Paper 22239894 Paper 22214528 Paper 22211895 Paper 21723747 Paper 21636809 Paper 21600277 Paper 21337131 Paper 20957395 Paper 20594553 Paper 20507991 Paper 20466987 Paper 20404919 Paper 20133903 Paper 20096667 Paper 20007578 Paper 19322705 Paper 19278572 Paper 19189073 Paper 19060123 Paper 19036858 Paper 18922799 Paper 18768885 Paper 18420491 Paper 18245563 Paper 18245560 Paper 17241110 Paper 17084284 Paper 17008596 Paper 16751175 Paper 16505177 Paper 16260187 Paper 16076470 Paper 15879496 Paper 12671045 Paper 12453678 Paper 12039445 Paper 11581294 Paper 11520119 Paper 11485910 Paper 11276765 Paper 10772656

Abstract

Core C, the Mouse Breeding and Microsurgery and Procedure Core will continue to serve all three Projects over all five years of the Program. There are two major functions of Core C: (1) The Mouse Breeding & Management Unit will continue to provide transgenic and null mice bred Into specific genetic backgrounds to each of the three projects of the Program. This Unit will provide sen/ices to mate and genotype the animals required for Projects 1-2-3. (2) The newly-formed Mouse Microsurgery and Procedure Unit has grown out of the expansion of the Program's studies. The goal of this Unit is to standardize all microsurgery procedures and procedures carried out by the Projects. This Unit will be responsible for lethal irradiation and bone marrow transplantation (Projects 2), femoral artery ligation for induction of hind limb ischemia (Project 2), assessment of reverse cholesterol transport (Project 1) and myocardial infarction (Project 3).

View original record on NIH RePORTER →